[1] Karimian G, Kirschbaum M, Veldhuis ZJ, et al. Vitamin E attenuates the progression of non-alcoholic fatty liver disease caused by partial hepatectomy in mice. PloS one, 2015,10:e0143121.
[2] Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science,2012,336:1262-1267.
[3] Celinski K, Konturek PC, Slomka M, et al. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease-14 months follow up. J Physiol Pharmacol,2014,65:75-82.
[4] Paolella G, Mandato C, Pierri L, et al. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World J Gastroenterol,2014,20:15518-15531.
[5] An YM, Jun DW, Lee SM. Development and application of low-carbohydrates and low-simple sugar nutrition education materials for non-alcoholic fatty liver disease patients. Clin Nutr Res,2015,4:250-258.
[6] Yasutake K, Kohjima M, Kotoh K, et al. Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World J Gastroenterol,2014,20:1756-1767.
[7] Maersk M, Belza A, Stdkilde-Jrgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr,2012,95:283-289.
[8] 冉莉. 膳食脂肪酸对非酒精性脂肪性肝病发生发展的影响. 第三军医大学,2014:1-60.
[9] de Wit N, Derrien M, Bosch-Vermeulen H, et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol,2012, 303:G589-G599.
[10] Parker HM, Johnson NA, Burdon CA et al. Omega-3supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol,2012,56: 944-951.
[11] Saboori S, Koohdani F, Nematipour E, et al. Beneficial effects of omega 3 and vitamin E co-administration on gene expression of SIRT1 and PGC1α and serum antioxidant enzymes in patients with coronary artery disease. Nutr Metab Cardiovasc Dis,2016, 26:489-494.
[12] Lavine DJE, Schwimmer DJB, Natta MMLV, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA,2011,305:1659-1668.
[13] Violi F, Cangemi R. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med,2010,363:1185-1186.
[14] Klein EA, Thompson IM Jr, Tangen CM,et al.Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA,2011,306:1549-1556.
[15] Reiter RJ, Tan DX, Osuna C,et al. Actions of melatonin in the reduction of oxidative stress. A Review. J Biomed Sci,2000,7:444-458.
[16] Gonciarz M, Gonciarz Z, Bielanski W, et al. The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study.J Physiol Pharmacol,2012,63:35-40.
[17] 徐孟川,齐燕,何芳,等.原花青素抗氧化损伤作用动物实验研究系统评价.营养学报,2016, 38:96-98.
[18] Ren T, Huang C, Cheng M. Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway. Oxid med cell longev,2014,2014:469059.
[19] Vendrame S, Daugherty A, Kristo AS, et al. Wild blueberry (Vaccinium angustifolium)-enriched diet improves dyslipidaemia and modulates the expression of genes related to lipid metabolism in obese Zucker rats. Br J Nutr,2014,111:194-200.
[20] Endo H, Niioka M, Kobayashi N, et al.Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One,2013,8:e63388.
[21] Alisi A, Bedogni G, Baviera G, et al. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther,2014,39:1276-1285. |
